Brugada Syndrome

• 

  Subject Areas on Research

  • A novel NaV1.5 voltage sensor mutation associated with severe atrial and ventricular arrhythmias. 
  • Baseline fragmented QRS increases the risk of major arrhythmic events in Brugada syndrome: Systematic review and meta-analysis. 
  • Brugada-like syndrome in infancy presenting with rapid ventricular tachycardia and intraventricular conduction delay. 
  • Ca2+/calmodulin-dependent protein kinase II (CaMKII) regulates cardiac sodium channel NaV1.5 gating by multiple phosphorylation sites. 
  • Calcium Channel Mutations in Cardiac Arrhythmia Syndromes. 
  • Current advances in the use of therapeutic hypothermia. 
  • Dissection of a quantitative trait locus for PR interval duration identifies Tnni3k as a novel modulator of cardiac conduction. 
  • Drug Provocation Testing in Brugada Syndrome: A Test of Uncertain Significance. 
  • ECG quantification of myocardial scar and risk stratification in MADIT-II. 
  • Electrocardiographic J Wave and Cardiovascular Outcomes in the General Population (from the Atherosclerosis Risk In Communities Study). 
  • Ethnicity and arrhythmia susceptibility. 
  • FGF12 is a candidate Brugada syndrome locus. 
  • Local anesthetics, neuraxial anesthesia, and the Brugada syndrome. 
  • Management of Ventricular Arrhythmias and Sudden Cardiac Death Risk Associated With Cardiac Channelopathies. 
  • Mosaic mutations in early-onset genetic diseases. 
  • Outcomes and predictors of recovery in acute-onset cardiomyopathy: A single-center experience of patients undergoing endomyocardial biopsy for new heart failure. 
  • Risk stratification of individuals with the Brugada electrocardiogram: a myth or a reality? 
  • Risks and challenges of implantable cardioverter-defibrillators in young adults. 
  • SCN5A mutation status increases the risk of major arrhythmic events in Asian populations with Brugada syndrome: systematic review and meta-analysis. 
  • Sodium channel kinetic changes that produce Brugada syndrome or progressive cardiac conduction system disease. 
  • The time for naming the Interatrial Block Syndrome: Bayes Syndrome. 
  • Treatment of arrhythmias by external charged particle beams: a Langendorff feasibility study. 
  • [A case of acute poisoning from aconitine with cardiac rhythm disorders]. 
• 

  Keywords of People

  • Landstrom, Andrew Paul, Assistant Professor of Pediatrics, Cell Biology
  • Pitt, Geoffrey Stuart, Adjunct Professor in the Department of Medicine, Medicine, Cardiology